Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other Operating Expenses (2016)

Historic Other Operating Expenses for Arrowhead Pharmaceuticals (ARWR) over the last 7 years, with Q4 2016 value amounting to $7.9 million.

  • Arrowhead Pharmaceuticals' Other Operating Expenses rose 1115.75% to $7.9 million in Q4 2016 from the same period last year, while for Sep 2017 it was $7.9 million, marking a year-over-year increase of 30689.63%. This contributed to the annual value of -$3.8 million for FY2016, which is 10926.11% down from last year.
  • As of Q4 2016, Arrowhead Pharmaceuticals' Other Operating Expenses stood at $7.9 million, which was up 1115.75% from -$26.1 million recorded in Q3 2016.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Other Operating Expenses peaked at $47.4 million during Q3 2012, and registered a low of -$26.1 million during Q3 2016.
  • Moreover, its 5-year median value for Other Operating Expenses was $4.8 million (2014), whereas its average is $6.2 million.
  • In the last 5 years, Arrowhead Pharmaceuticals' Other Operating Expenses skyrocketed by 24822.34% in 2015 and then crashed by 30738.19% in 2016.
  • Arrowhead Pharmaceuticals' Other Operating Expenses (Quarter) stood at $2.5 million in 2012, then grew by 21.48% to $3.0 million in 2013, then soared by 81.47% to $5.5 million in 2014, then soared by 30.04% to $7.1 million in 2015, then grew by 11.16% to $7.9 million in 2016.
  • Its Other Operating Expenses was $7.9 million in Q4 2016, compared to -$26.1 million in Q3 2016 and $7.7 million in Q2 2016.